文献
J-GLOBAL ID:202202292770778195
整理番号:22A1029361
ルキソリチニブを受ける骨髄増殖性腫瘍患者におけるBNT162b2ワクチンの第2用量後の抗体応答障害【JST・京大機械翻訳】
Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
著者 (12件):
Ikeda Daisuke
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Terao Toshiki
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Miura Daisuke
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Narita Kentaro
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Fukumoto Ami
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Kuzume Ayumi
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Kamura Yuya
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Tabata Rikako
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Tsushima Takafumi
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Takeuchi Masami
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
,
Hosoki Takaaki
(Department of Hematology, Kimitsu Central Hospital, Chiba, Japan)
,
Matsue Kosei
(Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan)
資料名:
Frontiers in Medicine (Web)
(Frontiers in Medicine (Web))
巻:
9
ページ:
826537
発行年:
2022年
JST資料番号:
U7079A
ISSN:
2296-858X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
スイス (CHE)
言語:
英語 (EN)